Cite
Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.
MLA
Xiong, Yunyun, et al. “Prestroke Statins, Progression of White Matter Hyperintensities, and Cognitive Decline in Stroke Patients with Confluent White Matter Hyperintensities.” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 11, no. 3, July 2014, pp. 606–11. EBSCOhost, https://doi.org/10.1007/s13311-014-0270-5.
APA
Xiong, Y., Wong, A., Cavalieri, M., Schmidt, R., Chu, W. W. C., Liu, X., Wong, K. S., & Mok, V. (2014). Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities. Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, 11(3), 606–611. https://doi.org/10.1007/s13311-014-0270-5
Chicago
Xiong, Yunyun, Adrian Wong, Margherita Cavalieri, Reinhold Schmidt, Winnie W C Chu, Xinfeng Liu, Ka Sing Wong, and Vincent Mok. 2014. “Prestroke Statins, Progression of White Matter Hyperintensities, and Cognitive Decline in Stroke Patients with Confluent White Matter Hyperintensities.” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 11 (3): 606–11. doi:10.1007/s13311-014-0270-5.